Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07125924) titled 'Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer' on Aug. 3.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Single (Participant).
Primary Sponsor: National Cancer Center, Korea
Condition:
Bladder Cancer
Radiation Cystitis
Intervention:
Device: Blad-Care (sodium hyaluronate 1.6%, 800 mg/50 mL, BioPlus Co., Ltd.)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: August 22, 2025
Target Sample Size: 54
Countries of Recruitment:
Korea, Republic of
To kn...